1
|
Lan J, Zou J, Xin H, Sun J, Han T, Sun M, Niu M. Nanomedicines as disruptors or inhibitors of biofilms: Opportunities in addressing antimicrobial resistance. J Control Release 2025; 381:113589. [PMID: 40032007 DOI: 10.1016/j.jconrel.2025.113589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 02/02/2025] [Accepted: 02/26/2025] [Indexed: 03/05/2025]
Abstract
The problem of antimicrobial resistance (AMR) has caused global concern due to its great threat to human health. Evidences are emerging for a critical role of biofilms, one of the natural protective mechanisms developed by bacteria during growth, in resisting commonly used clinical antibiotics. Advances in nanomedicines with tunable physicochemical properties and unique anti-biofilm mechanisms provide opportunities for solving AMR risks more effectively. In this review, we summarize the five "A" stages (adhesion, amplification, alienation, aging and allocation) of biofilm formation and mechanisms through which they protect the internal bacteria. Aimed at the characteristics of biofilms, we emphasize the design "THAT" principles (targeting, hacking, adhering and transport) of nanomedicines in their interactions with biofilms and internal bacteria. Furthermore, recent progresses in multimodal antibacterial nanomedicines, including biofilms disruption and bactericidal activity, and the types of currently available antibiofilm nanomedicines contained organic and inorganic nanomedicines are outlined and highlighted their potential applications in the development of preclinical research. Last but not least, we offer a perspective for the effectiveness of nanomedicines designed to address AMR and challenges associated with their clinical translation.
Collapse
Affiliation(s)
- Jiaming Lan
- Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China
| | - Jingyu Zou
- Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China
| | - He Xin
- Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China
| | - Jin Sun
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China
| | - Tao Han
- Department of Oncology, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China.
| | - Mengchi Sun
- Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.
| | - Meng Niu
- Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China.
| |
Collapse
|
2
|
Quiñones-Vico MI, Ubago-Rodríguez A, Fernández-González A, Sanabria-de la Torre R, Sierra-Sánchez Á, Montero-Vilchez T, Sánchez-Díaz M, Arias JL, Arias-Santiago S. Antibiotic Nanoparticles-Loaded Wound Dressings Against Pseudomonas aeruginosa's Skin Infection: A Systematic Review. Int J Nanomedicine 2024; 19:7895-7926. [PMID: 39108405 PMCID: PMC11302427 DOI: 10.2147/ijn.s469724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Accepted: 07/07/2024] [Indexed: 01/29/2025] Open
Abstract
Pseudomonas aeruginosa (P. aeruginosa) is a common nosocomial pathogen that can cause severe infections in critically ill patients. Due to its resistance to multiple drugs, it is challenging to treat, which can result in serious illness and death. Conventional treatments for infected wounds often involve the topical or systemic application of antibiotics, which can lead to systemic toxicity and the development of drug resistance. The combination of wound dressings that promote wound healing with nanoparticles (NPs) represents a revolutionary strategy for optimizing the safety and efficacy of antibiotics. This review assesses a systematic search to identify the latest approaches where the evaluation of wound dressings loaded with antibiotic NPs is conducted. The properties of NPs, the features of wound dressings, the antimicrobial activity and biocompatibility of the different strategies are analyzed. The results indicate that most research in this field is focused on dressings loaded with silver NPs (57.1%) or other inorganic materials (22.4%). Wound dressings loaded with polymeric NPs and carbon-based NPs represent 14.3% and 6.1% of the evaluated studies, respectively. Nevertheless, there are no clinical trials that have evaluated the efficacy of NPs-loaded wound dressings in patients. Further research is required to ensure the safety of these treatments and to translate the findings from the bench to the bedside.
Collapse
Affiliation(s)
- María I Quiñones-Vico
- Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, Granada, 18014, Spain
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Andalusian Network of Design and Translation of Advanced Therapies, Sevilla, 41092, Spain
- Medicine Department, School of Medicine, University of Granada, Granada, 18016, Spain
| | - Ana Ubago-Rodríguez
- Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, Granada, 18014, Spain
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Andalusian Network of Design and Translation of Advanced Therapies, Sevilla, 41092, Spain
| | - Ana Fernández-González
- Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, Granada, 18014, Spain
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Andalusian Network of Design and Translation of Advanced Therapies, Sevilla, 41092, Spain
| | - Raquel Sanabria-de la Torre
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Department of Biochemistry and Molecular Biology IIi and Immunology, School of Medicine, University of Granada, Granada, 18016, Spain
| | - Álvaro Sierra-Sánchez
- Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, Granada, 18014, Spain
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Andalusian Network of Design and Translation of Advanced Therapies, Sevilla, 41092, Spain
- Department of Biochemistry and Molecular Biology IIi and Immunology, School of Medicine, University of Granada, Granada, 18016, Spain
| | - Trinidad Montero-Vilchez
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Dermatology Department, Virgen de las Nieves University Hospital, Granada, 18014, Spain
| | - Manuel Sánchez-Díaz
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Dermatology Department, Virgen de las Nieves University Hospital, Granada, 18014, Spain
| | - José L Arias
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Granada, 18071, Spain
- Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, 18100, Spain
| | - Salvador Arias-Santiago
- Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, Granada, 18014, Spain
- Instituto de Investigación Biosanitaria Granada ibs.GRANADA, Granada, 18014, Spain
- Andalusian Network of Design and Translation of Advanced Therapies, Sevilla, 41092, Spain
- Medicine Department, School of Medicine, University of Granada, Granada, 18016, Spain
- Dermatology Department, Virgen de las Nieves University Hospital, Granada, 18014, Spain
| |
Collapse
|
3
|
Behshood P, Rezaei M. A glimpse into the use of silver-nanoparticles as a promising treatment for burn wounds. Burns 2023; 49:241-243. [PMID: 36220706 DOI: 10.1016/j.burns.2022.09.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Accepted: 09/15/2022] [Indexed: 01/06/2023]
Affiliation(s)
- Parisa Behshood
- Department of Microbiology, Young Researcher and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
| | - Mohammad Rezaei
- Department of Biotechnology, School of Science and Technology, Nottingham Trent University, Nottingham, UK.
| |
Collapse
|